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ABBREVIATIONS 
WHO – world health organization 
Hgb /Hb  – Hemoglobin  
RBCs  – Red Blood Cells 
Hct -  Hematocrit  
G6PD  – Glucose -6- Phosphate Dehydrogenase  
GI  – Gastro Intestinal  
HR  – Heart Rate  
SV  – Stroke Volume  
HF  – Heart Failure  
MCV  – Mean Cells Volume  
MCH  – Mean cells Hemoglobin  
MCHC  – Mean cells hemoglobin Concentration  
FL  – Femtolitre  
Pg  – Picogram  
TIBC  – Total Iron Binding Capacity  
RDW  – Red  blood cells Distribution Width  
ctHb  – Concentration of Hemoglobin  
ICSH  – International Committee Standardization in  
  Hematology  
HICN – Hemglobincyanide  
Nm  – Nanometer  
Mg  – milligram  
Kg – kilogram  
US  – United states  
IV  – intravenous  
IDA – Iron Deficiency Anemia  
ID – Iron Deficiency  
CBC – Complete Blood Count 
FCM – Ferric Carboxy Maltose    
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INTRODUCTION 
I. ANAEMIA 
 Anaemia is not one disease but a condition that result from number of 
different pathogensis.  It can be defined as a reduction from normal haemoglobin 
quantity in the blood. 
According to WHO Anaemia is a condition it which number of red blood 
cells or their oxygen – carrying is insufficient to meet physiologic needs, which vary 
by age, sex, attitude, smoking and pregnancy status.  
 Iron deficiency is thought to be the most common cause of anaemia globally, 
however other conditions, such as folate, vitamin B12 and Vitamin A deficiencies, 
chronic inflammation parasitic infections and inherited disorders can all cause 
anaemia. 
II. HAEMGLOBIN 
 Haemoglobin is an iron rich protein inside red blo0d cells that carries oxygen 
from lungs to tissues and organs in the body and carries carbon dioxide back go 
hings and gives blood litres red colour. 
 Therefore, total Haemoglobin concentration primary depends on the number 
of RBCs in the blood sample.  Medical conditions that impact the number of RBCs 
will also affect Haemoglobin concentration. 
Reference Rage:  
 Males – 14-18 g/dL (or) 140-180 g/dL 
 Females – 12-16 g/dL (or) 120-160 g/L 
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Red Blood cell indices  
 RBC indices (also known as wintrobe indices) are useful in the classification 
of anaemia.  These indices include, 
(a) The MCV 
(b) The mean cell haemoglobin (MCH) 
(c) And the MCHC which calculated as following equations.: 
a) MCV = ு௖௧ ௫ ଵ,଴଴଴
ோ஻஼ ሺ௜௡ ௠௜௟௟௜௢௡௦ / μ௅ሻ = 76-100 (in μm3) 
b)  MCH = ு௚௕ ሺ௜௡ ௚/ௗ௅ ௫ ଵ଴ሻ
ோ஻஼ ሺ௜௡ ௠௜௟௟௜௢௡௦ / μ௅ሻ = 27-33 (in pg) 
c) MCHC = ு௚௕ ሺ௜௡ ௚/ௗ௅ሻ
ு௖௧
 = 33-37 (in g/dL) 
A) Mean Cell Volume 
 The MCV detects changes in cell size. A decreased MCV indicates a 
micrcytic cell, which can result from iron-deficiency anaemia. 
 A large MCV indicates macrocytic cell which can be caused by vitamin B12 
or folic acid deficiency. 
B) Mean cell haemoglobin 
 The MCHC is more reliable index of RBC Hgb than MCH.  MCHC 
measures the concentration of Hbg where as MCH measures the weight of Hgb in 
the average RBC. 
 In normochromic anemias changes in size of RBCs (MCV) are associated 
with corresponding changes in weight of Hgb (MCH), but the concentration of 
haemoglobin (MCHC) remains normal. 
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TABLE – 1 
CLASSIFICATIONS OF ANEMIA 
I. PATHOPHYSIOLOGIC (Classifies anemias based on pathophysiologic 
presentation)  
1. Blood Loss:  
Acute: Trauma, ulcer, haemorrhoids 
Chronic: Ulcer, vaginal bleeding, aspirin indigestion. 
2. Inadequate RBCs production: 
Nutritional deficiency: Vitamin B12, folic acid, iron 
Erythroblast deficiency: Bone marrow failure, Caplastic anemia, irradiation, 
chemotherapy, folic acid antagonists or bone marrow infilteration, leukemia, 
lymphoma, myeloma, metastatic solid tumors, mylofibrosis 
3. Endocrine deficiency:  
Pituitary, adrenal, thyroid, testicular 
Chronic disease: Renal, liver, infection, granulomatous, collagen vascular. 
4. Excessive RBC destruction: 
Intrinsic factors: Heredity (G6PD), abnormal  haemoglobin synthesis. 
Extrinsic factors: auto immune reactions, drug reactions, infection (endotoxins)  
II. MORPHOLOGIC (classifies anemia by Pad blood cell size) and haemoglobin 
content  
1. Macrocytic: Detective maturation with decreased production. 
Megaloblastic: Pernicious (vitamin B12 deficiency), folic acid deficiency. 
2. Normochromic, normocytic 
Recent blood loss 
Hemolycsis 
Chronic disease 
Renal failure 
Autoimmune 
Endocrine 
3. Microcytic, hyperchromic 
Iron deficiency  
Genetic abnormalities: Sickell cell, thalassemia 
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IV. EPIDEMIOLOGY  
 Anaemia is one of the most common condition in the world and results in 
significant morbidity and mortility in the developing world.[1] 
 In2011, 29% (496 million) of non-pregnant women and 38% (32 million) of 
pregnant women aged 15-49 years where anaemic.[5] 
 Anaemia is major health problem for adult by affecting 55% of women and 
24% of men. The prevalence of Anaemia for ever married women in age group of 
15-49 has increased from 52% in NFHS-2 to 56% in NFHS -3 and this anaemia 
confines to be a serious problem in India[6]. 
V. AETIOLOGY  
 The low haemoglobin level that defines anaemia results from two different 
mechanisms. 
• Increased haemoglobin loss do to  either  
Haemorrhage (Red cell loss) or  
Haemolysis (Red cell destruction) 
• Reduced haemoglobin synthesis due to 
Lack of nutrient (or)  
Bone marrow failure  
 Each of these mechanisms includes a number of disorder that required  
specific and  appropriate therapy 
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A. GENTIC ETIOLOGY INCHIDE THE FOLLOWING 
• Haemoglobin pathies  
• Thalassemia  
• Enzyme abnormalities of the glycolytic pathways 
• Detects of the RBC cytoskeleton 
• Congenital dyserythropoietic anaemia 
• Rh null  disease  
• Heredity xerocytosis  
• Abetalipoproteinemia  
• Fanconi anemia  
B. NUTRITIONAL ETIOLOGIES INCLUDE THE FOLLOWING  
• Iron deficiency 
• Folate deficiency 
• Vitamin B12 deficiency 
• Starvation and generalized malnutrition 
C. PHYSICAL ETIOLOGIES INCLUDE THE FOLLOWING 
• Truma 
• Burns 
• Frostbite 
• Prosthetic value and surfaces 
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D. CHRONIC DISEASE AND MALIGNANT ETIOLOGYIES INCLUDE 
THE FOLLOWING 
• Renal Disease 
• Hepatic Disease 
• Chronic infections 
• Neoplasia 
• Collagen vascular diseases 
E. INFECTIOUS ETIOLOGIES INCLUDE THE FOLLOEING 
• Viral- hepatitis, infectious mononucleosis, cytomegalaovirus 
• Bacterial- clostridia,  gram negative sepsis 
• Protozoal- malaria, leishmaniasis, toxoplasmosis. 
Thrombotic thrombocytopenic purpura (TTP) and haemolytic –aremic 
syndrome may be cause anaemia. Heredity spherocytosis either may present as a 
server hemohytic anaemia (or) a symptomatic with hemolysis also deficiency in 
G6PD may manifest as chronic haemolytic anaemia (or) exist without anaemia until 
an oxidant medication given to the patient. 
In emergency department, acute hemorrhage is by far the most common 
etiology for anaemia. Drugs (or) chemical commonly cause the aplastic and 
hypoplastic group of disorders which certain are dose related while others are 
idiosyncratic  
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Such as:  Being exposed to a sufficient dose of 
• Inorganic arsenic 
• Bezene 
• Racliation 
• Or chemotheraouetic agents for treatment of neoplastic diseases which 
develops bone marrow depression. 
VI. SIGNS AND SYMPTOMPS 
Signs and symptoms of anemia vary with the degree of RBC reduction and 
with the time interval during which it develops. In tissue hypoxia caused by the 
decreased oxygen carrying capacity of reduced RBC mass. Which result in perfusion 
of tissues. Such as 
• Skin 
• Mucous membrane 
• Extremities 
Slowly developing anaemia can be a symptomatic initially or include 
symptoms  
Such as:  
• Slight exertional dyspnea 
• Increased anagina 
• Fatigue 
• Or malaise 
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UNCORRECTED HYPOXIA CAN LEAD TO A NUMBER OF COMPLICATIONS IN 
Cognition, quality of life, and respiratory and GI systems. In sever anaemia 
(hgb<8gldL) stroke volume and heart rate increased inorder to attempt oxygen 
delivery improvement to tissue. Theses change in HR and SV can Result in systole 
murmurs, argina pectorios, high output, HF, pulmonary congestion, ascites and 
edema. 
However, anaemia is generally not tolerated in patients with  
• Cariac disease  
• Skin and mucous membrane pallor  
• Jaundice 
• Smooth (or) beety tongue 
• Cheilosis 
• And spoon shaped nail (koilonychias) 
Also may be associated with sever anaemia of different etiologies thus, acute 
onset anemia is characterized by cardiorespiratory symptoms such as 
• Tachy cardia 
• Lightheadedness 
• And breathlessness 
While chronic anaemia is characterized by 
• Weakness 
• Fatigue 
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• Headache 
• Vertigo 
• Faintness 
• Cold sensitivity  
• Pallor 
• Loss of skin tone dree to hypoxia 
In case   of iron deficiency anemia is characterized By 
• Glossal pain 
• Smooth toung 
• Reduced salivary flow 
• Pica (compulsive eating of non food items) 
• And pagophagia (compulsive eating of ice) 
These symptoms are not usually seen until Hbg concentration is less than 
9g/dL. While vitamin B12 and folate deficiency anaemia are characterized by 
• Pallor 
• Incerus 
• And  gastric mucosal atrophy 
Vitamin B12 anemia is distinguisted by neuropsy chiatric abnormalities (e.g, 
numbness, paresthedias, irritability) which are absent in folate deficiency anemia 
patients. 
  
Chapter 1 Introduction 
Department of Pharmacy Practice  10 JKKMMRF College of Pharmacy 
RISK FACTORS 
 There are a number of conditions that can increase your risk of anaemia 
some example are 
• Low diet in iron, vitamins and miner als 
• Chronic diseases such as, kidney disease, gastritis, colitis, rheumatoid 
arthritis and related diseases, thyroid disease and heart failure. 
• Blood loss during surgery or injury, excessive blood draws, heavy menstrual 
cycle 
• Family history of  inberited anaemia (e.g, sickle cell or thalessemia) 
• Inability to absorb iron caused by intestinal disorders such as crohn’s 
disease, celiac  disease or gastric bypass surgery 
• Adult 65 years of age and older 
• Women of child bearing age 
• Infant under 2 years old 
VII. DIAGNOSIS  
 Initial evaluation of anemia involves a complete blood cell count, 
reticulocyte index and examination of stool for occult blood. 
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TABLE-2 NORMAL HEMATOLOGIC VALUES 
TEST REFERANCE RANGE (YEARS) 
Hgb  (g/dL) 18 – 48 
M:13.5 -17.5 
F:120 – 16.0 
HCT (%) M: 41-53 
F:36-46 
MCV (fl) 80-100 
MCH(%) 31-37 
MCH(pg) 26-34 
RBC (Million/mm3) 4.5-5.9 
Reticulocyte count, absolute (%) 0.5-1.5 
Serum iron (mcg/dL) M:56-160 
F:40-150 
TIBC (mcg/dL) 250-400 
RDW(%) 11-16 
Ferritin (ng/mL) M:15-200 
F:12-150 
Folate (ng/mL) 1.8-16.00 
Vitamin B12 (pg/mL) 100-9000 
Erythropoietin (milliunits /mL) 0-19 
 
VARIES BY ASSAY METHOD 
¾ Macro anemaia are characterized by increased in MCV (110 – 140 fl ) 
¾ Vitamin B12 and folate concentrations can be measured to differntoate between  
the two deficiencies anemias. 
Chapter 1 Introduction 
Department of Pharmacy Practice  12 JKKMMRF College of Pharmacy 
¾ A vitamin B12 value of less than 150pg/ml together with appropriate peripheral 
amear and clinical symptoms, is a diagnostic vitamin B12 deficiency anemia 
¾ Adecreased RBC folate concentration (less than 150ng/ ml) appears to be a 
better indicator of folate deficiency anemia than a decreased serum folate 
concentration (less than 3ng/ml)[8] 
¾ Iron deficiency is the most common cause of microcytic anemia, up to 40 
percent  of patients with iron deficiency anemia will have normocytic 
erythrocytes (10), As such, iron deficiency should still be considered in all cases 
of anemia unless the MCV is greater than 95fl. Because this cut off has a 
sensitivity of 97 percent [11] 
¾ The most sensitive laboratory for iron deficiency anemia is decreased               
serum forritin (storage iron), which should be interpreted in conjunction with 
decreased transferring saturation and increased TIBC. White Hgb, HCT and 
RBC indices remain n ormal unitl later stages of iron-deficiency anemia. 
¾ Hemolytic anemias tend to be normocytic and normochromic and to have 
increased levels of reticulocytes, lactic dehydrogenase and indirect bilirubin. 
¾ Elderly patients with symptoms of anemia should undergo a complete blood cell 
cocent will peripheral smear and reticulocyte count, and other laboratory studies 
as needed to determine the etiology of anemia.[8]. 
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Table 3: Haemoglobin levels to diagnose anemia (g/L) 
Population Non anemia 
Anemia 
Mild Moderate Severe 
Non-pregnant women (15 years 
of age and above)  
120 (or) 
higher 
110-119 80-109 Lower than 
80 
Pregnant women 110 or 
higher 
100-109 70-99 Lower than 
70 
Men (15  years of age and 
above) 
130 or 
higher 
110-129 80-109 Lower than 
80 
 
MEASUREMENTS OF ctHb 
1. Historical Perspective  
The first test of Hb measurement devised more than a century ago[13] involved 
adding drops of distilled water to a measured volume of blood units until it colour 
matched that of an artificial colour standard. 
Alter modification[14] involved first saturating blood with coal gas (carbon 
monoxide) to convert hemogloibin to the more stable carboxyhemoglobin.  Modern 
hemoglobinometry dates from the 1950, following development of 
spectrophotometry and the hemiglobincyanide (cynamethemoglobin) method.  
 Adaptation of this method and others for use in automated hemotology 
analyzers followed.  Over the past two decades advances have focused on 
development of methods which allow point-of-care testing (POCT) of haemoglobin. 
 This section deals with consideration of some of the methods currently used 
in the laboratory and then with those POCT methods done outside the laboratory. 
Hemiglobincyanide – A spectrophotometric method 
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 Nearly 40 years after it was first adopted as the reference method for measuring 
haemoglobin by ICSH [15], The HICN test remains the recommended method of the 
ICSH [16] against which all new ctHb methods are judged and standardized. 
i) Test Principle  
 Blood will be diluted with a solution containing potassium ferricyanide and 
potassium cyanide.  In which potassium ferricyanide oxidizes iron in heme to the ferric 
state to form methemoglobin, which is converted to HICN by potassium cyanide. 
 HICN is a stable colored product, which in a solution has an absorbance 
maximum at 450 nm and strictly obeys bear-lambert’s law.  
 The diluted sample absorbance at 540 nm is compared with absorbance at the 
same wave length of a standard HICN solution whose equivalent haemoglobin 
concentration is known.  
 Most haemoglobin derivatives such as oxyhemoglobin, methemoglobin and 
carboxyhemoglobin but not sulfhemoglobin are converted to HICN and therefore 
measured by this method.  
a) Reagent diluents (modified Drab kin Solution)[17] 
• Potassium ferricyanide (K3Fe(CN)6) 200mg 
• Potassium cyanide (KCN) 50mg 
• DIhydrogen potassium phosphate (KH2PO4) 140mg 
• Non-ionic detergen (e.g. Tritonx-100) 1 ml 
• Above diluted to 1000ml in distilled water. 
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b) Manual method  
 24 HL of blood is added to 5.0 ml reagent, mixed and left for 3 minutes. 
Absorbance is read at 540 nm against a reagent blank.  The absorbance of HICN 
standard is measured in the same way.  
(c) ICSH HICN standard  
 The standard HICN solution manufactured and assigned a concentration 
value according to very precise criteria laid down and reviewed periodically by 
ICSH. [16] 
(d) Advantages of HICN  
• International standard – accurate. 
• Easily adapted by automated hematology analyzer. 
• Well established and thoroughly investigated ICSH recommended. 
• Inexpensive reagent  
d) HICH Disadvantages  
• Manual process requires accuracy in popetting and spectrophotometer. 
• Reagent hazardous (Cyanide) 
• Subject to interference from raised lipid, plasma proteins and leucocytes 
numbers.  
PATHOPHYSIOLOGY 
 Anemias can be classified on the basis of RBC morphology, etiology or 
pathophysiology (Table 1) 
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 Morphologic classifications are based on cell size. Macrocytic cells are 
larger than normal and associated with deficiencies of vitamin B12 or folate.  While 
microcytic cells are smaller whereas normocytic anaemia may be associated with 
recent blood loss (or) chronic disease. 
 Iron-deficiency anemia can be caused by inadequate dietary intake, 
inadequate GI absorption increased iron demand (e.g. pregnancy), blood loss and 
chronic disease.  
 Vitamin B12 and folate – deficiency anemias can be caused by inadequate 
dietary intake, decreased absorption, and inadequate utilization, also intrinsic factor 
can cause decreased absorption of vitamin B12 (i.e., pernicious anemia). 
 Folate deficiency anemia can be caused by hyper utilization due to 
pregnancy, haemolytic anemia, myelofibrosis, malignancy, chronic inflammatory 
disorders, long-term dialysis or growth spurt.  
 Drugs can cause anemia by reducing absorption of folate such as phenytoin 
or by interfering with corresponding metabolic pathways such as methotrexate.  
 Anemia of chronic disease is associated with chronic infectious or 
inflammatory processes, tissue injury or conditions that release pro inflammatory 
cytokines.  
 This pathogensis is based on:  
- Shortened RBC survival.  
- Impaired marrow response. 
- And disturbance of iron metabolism 
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Age related reduction in bone marrow reserve can render the elderly patient 
more susceptiable to anemia that’s caused by multiple minor and unrecognized 
disease (e.g. nutritional deficiencies) which negatively effect erythropoiesis.  
Hemolytics anemia results from decreased RBC survival time due to 
destruction in the spleen or circulation. 
Most common etiologies are:  
- RBC defects (e.g. heredity spherocytosis) 
- Alter Hgb solubility or stability (sicklecell anemia) 
Some drugs cause direct oxidative damage to RBCs such as phenytoin and 
Phenobarbital. [8] 
Erythropoiesis 
 Erythropoietin is a hormone produced by the cells of the renal cortex.  The 
kidney respond to hypoxia and anemia by increasing the production of 
erythropoietin.  The red cells progenitors BFU-E and CFU-E have receptors on their 
faces.  
 When erythropoietin binds to these receptors, it promotes differentiation and 
division and consequently increased erythropoiesis. [1] 
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Pluripotent stem cell 
 
Erythroid burst forming unit (BFU-E) 
 
Erythroid colony forming unit (CFU-E) 
 
Erythroblast (normoblast) 
 
Reticulocyte 
 
Mature red cell (erythrocyte) 
Figure 1: Simplified diagram of some of the stages within erythropoiesis. 
TREATMENT : 
A)  IRON-DEFICENCY ANEMIA : 
Oral iron therapy with soluble ferrous iron salts which are not enteric coated 
and are not slow or sustained release, daily recommended at a daily dosage of 200 
mg in two or three divided doses. 
Diet plays significant role because iron is poorly absorbed from, the 
vegetables, grain products, dairy products and eggs ; iron is best absorbed from : 
meat, fish and poultry. whereas the typical daily requirements of iron are : 
Table No-4 : Daily Iron requirements[1] 
Normal range Category 
0.5 mg Infant (0-4 months) 
1.8 mg  Adolescent male 
2.4 mg  Adolescent female 
0.9 mg Adult male 
2.0 mg  Menstruating female  
3-5 mg In pregnancy 
0.9 mg  Postmenopausal female 
Within bone 
marrow 
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Administration of iron with a meal decreases absorption by more than 50 percent but 
may be needed to improve tolerability . 
Table No. 4 : Oral iron products : 
Elemental iron provided  Elemental iron (%) Salt  
60-65 mg/324-325 mg tablet 
18mg iron/5 ml  syrup  
44 mg iron/5ml syrup  
15 mg iron/0.6 ml drop 
             20 Ferrous sulfate 
65 mg /200 mg tablet  
60 mg/187 mg tablet 
50 mg/160 mg tablet  
 
              30                  Ferrous sulfate 
 ( exsiccated) 
36 mg/325 mg tablet  
27 mg/240 mg tablet  
              12 Ferrous gluconate  
33 mg/100 mg tablet  
63-66 mg/200 mg tablet  
106 mg/324-325 mg tablet 
15 mg/0.6 ml drop 
33 mg/5 ml suspension 
              33 Ferrous fumarate  
150 mg capsule  
50 mg tablet  
100 mg/5 ml elixir 
             100        Polysaccharide iron 
complex 
50 mg caplet               100 Carbonyl iron  
 
Parentral iron maybe required for patients with: iron malabsorption, 
intolerance of iron therapy and incompialnce .furthermore the replacement dose 
depends on etiology of anemia and hemoglobin concentration. 
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Available Parentral iron preparations have similar efficacy but different  
pharmacologic, pharmacokinetics and safety profiles  the new products are, sodium 
ferric gluconate and iron sucrose which appeared to be well tolerated when 
compared to iron dextran.[8] 
B)  Folate- Deficiency Anemia : 
folate-deficency anemia usually manged by replacement therapy. The 
duration of treatment depends on the cause of the deficiency. Changes in dietary 
habits or removal of any precipitating factor can be considered. 
The normal daily Requirement of folic acid is approximately 100µcg a day ; 
although the usual doses are given are 5-15 mg a day , and because of these large 
doses sufficient folate is absorbed. Therefore Parentral folic acid treatment is not 
normally required, Treatment for 4 months will normally be sufficient to ensure the 
folate deficient red cells are replaced.[1] 
Oral folate 1 mg daily for 4 months should be sufficient to overcome folate-
deficiency anemia , if malabsorption is present , the daily dose should be elevated 
and increased to 5mg.[8] 
C) Vitamin B12-Deficiency Anemia : 
The majority of patients with vitamin B12 deficiency require lifelong 
replacement therapy. since the anemia has developed slowly the cardiovascular 
system does not tolerate blood transfusion very well and is easily overloaded.  
The standard treatment is hydroxocobalamin 1 mg intramuscularly three 
times a week for two weeks then 1 mg every 3 months. where there is neurological 
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involvement , slightly higher regimen is recommended, 1 mg every 2 months . Its 
retain in the body longer than cynocobalamin and reaction to it is very rare .US 
texts recommend cyanocobalamin rather than hydroxoxobalamin because the fear 
that some patients appear to develop antibodies to the vitamin B12 transport protein 
complex in the serum.  
A small amount of passive absorption of vitamin B12 is occurred from the 
gastro-intestinal tract. High (1 mg) daily oral and sublingual doses of 
cyanocobalamin are absorbed in sufficient quantities to manage the pernicious 
anemia. 
The Red cells reurn to normal and the platelets count rises to normal (or even 
higher) after 7-10 days. The hemoglobin takes much longer to returns to normal, it 
should rise approximately 2-3 g/dL each fortnight .neurological damage maybe 
irreversible. [1] 
C) Anemia Of Chronic Disease : 
Treatment of anemia of chronic disease is less specific than that of other 
anemias and should focus on correcting reversible causes. Iron therapy is not 
effective when inflammation is present. RBC TRANSFUSIONS are effective but 
should be limited to episodes of inadequate oxygen transport and Hgb of 8 to 10 
g/dL.  
Epoetin alfa can be considered, especially if cardiovascular status is 
compromised , but the response can be impaired in patients with anemia of chronic 
disease (off-label use) . The initial dosage is 50-100 units/kg three times weekly. if 
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Hgb does not increase after 6-8 weeks , the dosage can be increased to 150 units/kg 
three times weekly. Epoetin alfa is usually well tolerated.  
D) Other Types Of Anemias : 
Patients with other types of anemias require appropriate supplementation 
depending on the etiology of anemia. In patients with anemia of critical illness, 
parentral iron is often utilized but is associated with a theoretical risk of infection. 
Routine use of epotein alfa or RBC transfusions is not supported by clinical studies.  
Anemia of prematurity is usually treated with RBC transfusions, the use of 
epotein alfa is controversial. In the pediatric population, the daily dose of elemental 
iron administered as iron sulfate is 3 mg/kg for infants and 6 mg/kg for older 
children for 4 weeks if response is seen , iron should be continued for 2 -3 months to 
replace storage iron pool. 
While treatment of hemolytic anemia should be focusing on correcting the 
underlying cause. There is no specific therapy for glucose-6-phosphate 
dehydrogenase deficiency, so treatment consists of avoiding oxidants medications 
and chemicals. steroids, other immunosuppressants , and even splenectomy can be  
indicated to reduce RBC destruction.[8] 
During acute episodes of haemolysis, the patient should be kept well 
dehydrated to ensure good urine output to prevent hemoglobin damaging the kidney, 
blood transfusions maybe necessary. Vitamin E (an antioxidant) appears to have 
little clinical benefits in preventing haemolysis. 
The common drugs implicated in causing haemolysis in G6PD deficiency: 
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1] Drugs to be avoided in all variants : 
Ciprofloxacin  
Dapsone 
Methylene blue  
Primaquine (reduced dose may be used in milder variants) 
Nalidixic acid  
Sulphonamides (including co-trimoxazole) 
2] Drugs to be avoided in more sever variants : 
Aspirin (low dose under supervision) 
Chloramphenicol 
Chloroquine (may be acceptable in acute malaria) 
Menadione  
Probenecid 
Quindine  
Quinine (acceptable in acute malaria) 
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LITERATURE REVIEW 
Quin Y 18 et al., (2013) conducted a study aimed to investigate the 
relationship of anemia and body mass index (BMI) among adult women in Jiangsu 
province, China. Data was collected in sub-national cross-sectional survey and 1,537 
women aged more than 20 years were included in the analysis. 31.1% of Chinese 
women were anemic. The prevalence of overweight, obesity and central obesity was 
34.2%, 5.8% and 36.2% respectively. The study concluded that women with 
overweight/obesity or central obesity were less likely to be anemic as compared to 
normal weight women. 
Rakesh PS19 et al.,(2017) conducted a study aimed to identify the prevalence 
of anemia in Kerala and to comment on its trend across previous 25 years using 
google scholar searches and PubMed and scanning of reference lists are used to 
identify studies. All studies based on population on anemia from kerala, irrespective 
of it design since first of January 1990 to 31st December 2015. The prevalence of 
anemia was found to be around 30% among adolescent girls from recent study 
report and prevalence of sever anemia was less than 1% in all studies, anemia 
among tribal women and children were in range of 78.3% to 96.5%. The study 
concluded that current prevalence of anemia in Kerala is unclear and these results 
cannot be combined due to non uniform hemoglobin estimation method. 
Kumari R20 et al.,(2017) conducted a study to find out the prevalence of 
IDA in adolescent girls in a tertiary care hospital. Using cross-sectional study was 
done in biochemistry laboratory of Indira Gandhi  Institute of Medical Sciences, 
Patna, Bihar, India for a period of six months duration, study result was out of 200 
girls were found to be anemic. 50% adolescent girls were found to be anemic, of the 
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total 43.3% were mildly, 3.3% were moderately and 3.3% were severely affected by 
anemia. the study concluded that as the prevalence of anemia is 50%, it needs 
intervention for its prevention and control. 
Sherwani RK21 et al.,(2008) has conducted a study for the prevalence of 
iron deficiency anemia in chronic diarrhea and celiac disease. it includes 45 children 
between 1-12 years with chronic diarrhea who underwent investigation hemoglobin 
with GBP, RBC indices, serum iron and TIBC. 30 cases (66.7%) were male and 15 
cases (33.3%) females. If no noted improvement after 2 weeks of treatment they will 
be subjected to duodenal biopsy, if biopsy showed features of celiac disease then 
antiendmysial antibody test was performed to substantiate the diagnosis 8 (17.8%) 
cases had watery diarrhea  and 20 (44.4%) semi formed and 17 (37.8%) had watery 
and semi formed diarrhea. bloody diarrhea was present in 5 (11.1%) and abdominal 
distension in 21 cases (46.7%). pallor is seen in all the cases. The study conclusion 
was a better awareness of the profile and early detection of celiac disease would help 
detection of management of iron deficiency associated with celiac disease. 
Mehta BC22 et al.,(2007) has conducted a study about nutritional anemia 
(NA) which is common in India while iron deficiency (ID) is a well recognized 
cause of NA, so the students were given a questionair to elicit anemia related 
symptoms. blood was collected for CBC test, serum ferritin, folic acid and vitamin 
B12. Students of polytechnic received hematinics at bed time during their menstrual 
cycle whereas inmate of students whome received hematinics at bed 3 days a week. 
After 6 months blood test were repeated once again in those who completed 
treatment students were divided into three groups. 1. Control group with Hb 12.0 
g/dl or more and ferritin15 ng/ml or more, 2. ID group with Hb 12.0 g/dl or more 
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and ferritin less than 15.0 ng/ml and Iron Deficiency Anemia (IDA) group with Hb 
less than 12.0 g/dl and ferritin less than 15.0 ng/ml. Result was found that Median 
age-16 years (range 10–25). Anemia (Hb < 12.0 g/dl)-94 (34.6%); MCV < 80 fl-153 
(56.3%); MCH < 27 pg-167 (61.4%); Ferritin < 15.0 ng/ml-161 (59.2%); Folic acid 
< 3.5 ng/ml-34 (12.5%); Vitamin B12 < 258 pg/ml-133 (48.9%) Pre-therapy: (1) 
Hb, MCV, MCH and ferritin significantly lower in ID and IDA Groups compared to 
control group. (2) Hb, MCV, MCH and Ferritin significantly lower in IDA Group as 
compared to ID Group. 
Nutritional anemia is common amongst asymptomatic young female 
students, Deficiencies of iron, folic acid and vitamin B12 are common and coexist, 
105 mg elemental iron for 3 days in a week for 6 months is not adequate to correct 
IDA. 105 mg iron for 3 days in a week is enough to correct ID, Non-anemic 
individuals with ID have iron deficient erythropoiesis,  Non-anemic individuals 
without ID, in this cohort, also had iron deficient eryhtropoiesis. 
Jayabose S23 et al.,(1993) conducted a study to evaluated the safety and 
efficacy of a new transfusion regimen for children with severe anemia, 22 
consecutive patients with severe anemia (hemoglobin < 5 g/dl) of gradual onset 
requiring transfusion of packed red blood cells (PRBC) were studied. The 
transfusion regimen consisted of continuous infusion of PRBC at the rate of 2 
cc/kg/h until the desired volume was given. Throughout the transfusion, the patients 
were closely monitored for any clinical signs of heart failure. 
The result was found to be No patient developed any signs of cardiac failure 
or increase in the heart rate during or after the completion of transfusion. All 
patients had a decrease in the heart rate by the completion of transfusion. The mean 
Chapter 2 Literature Review 
Department of Pharmacy Practice  27 JKKMMRF College of Pharmacy 
decrease in the heart rate was 28% of the pretransfusion heart rate (range 12-44%) , 
they concluded that children with sever anemia of gradual onset requiring 
transfusion therapy, continuous transfusion of PRBC at the rate of 2 cc/kg/h is safe 
and effective regimen resulting in the hematocrit level. 
Kaur24  et al.,(2018) has conducted a study which was aimed to to evaluate 
dietary intake, prevalence, and the effect of anemia on various morphophysiological 
variables among postmenopausal women, its a community-based sample survey, A 
total of 250 postmenopausal women aged 45-80 years from various parts of 
North India participated in the study. Anthropometric measurements, hemoglobin 
concentration, and bone mineral density (BMD) were assessed the prevalence of 
anemia was reported to be 85.2% among postmenopausal women, The intake of 
nutrients such as calcium, iron, and protein and energy was lower among anemic 
women than nonanemic women. Anemia was not only the result of aging but also 
unbalance and inadequate dietary intakes. 
Mishra25 et al.,(2018) conducted a study to evaluate the safety and efficacy 
of FCM in treating anemia in patients of menorrhagia. Thus avoiding blood 
transfusion, It was an open, single arm observational study including 90 women of 
age more than 30 years with definitive diagnosis of menorrhagia with IDA and 
hemoglobin (Hb) levels between 4 gm% and 11 gm%. Intravenous ferric 
carboxymaltose (FCM) (500-1500 mg) was administered, and the improvement in 
blood indices was assessed after three weeks of total dose infusion, Blood indices 
measured pre-FCM and 3 weeks post-FCM showed a mean increase in Hb from 
8.33±1.10 to 10.89±1.02 with a statistically significant P < 0.01. There was a 
statistically significant rise of packed cell volume, serum ferritin, and serum iron in 
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the post-FCM blood levels after three weeks. Its concluded that the Intravenous 
FCM is an effective and a safe treatment option for IDA with a single administration 
of high dose without serious adverse effects obviating the need for blood transfusion 
before surgery. 
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AIM AND OBJECTIVES 
The study is conducted and concerned with montoring of haematinics and 
blood transfusion therapy prescribing patterns in order to : 
To analyze the prescribing patterns of drugs used for anemia treatment. 
To assess blood transfusion therapy for anemic patients. 
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PLAN OF STUDY 
PHASE I :  
 1] PRELIMINARY LITERATUTRE SEARCH 
 2] DESIGNING STUDY PROTOCOL  
 3] DATA COLLECTION FORM  
PHASE II :  
 1] LITERATURE SURVEY  
 2] DATA COLLECTION  
 3] DATA ANALYSIS  
PHASE III :  
 RESULT AND DISCUSSION 
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METHODOLOGY 
STUDY DESIGN: 
Retrospective observational study. 
STUDY LOCATION: 
The study was carried out in a tertiary hospital, on inpatients medical records 
from medical ward. 
SAMPLE SIZE: 
Sample size in this study is 63 patients who diagnosed with anemia and got 
treatment at the hospital.  
STUDY DURATION: 
Six months.  
INCLUSION CRIETERIA: 
Male and female patients. 
Patients received oral / IV haematincs. 
Patients received blood transfusion therapy. 
Patients over 18 years of age. 
EXCLUSION CRIETERIA: 
Patients under 18 years of age. 
Pregnant patients were excluded from the study. 
SOURCE OF DATA : 
The data was collected from patients case reports at medical repot 
department (MRD).   
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CONCLUSION 
The study is used to assess age group and the gender of the respondant 
involved in the study, Majority of anemic patients were females and in the age 
between 18 to 40 years. 
The prescribed hematinics to anemic patients were fully insignificance, 
because most of these patients were readmitted for blood transfusion therapy which 
was the majority of the cases were treated with. 
The anemic patients should be given a chart of nutrition and food that 
containing iron , Folate and Vitamin B12 to increase the hemoglobin level along side 
with the prescribed hematinics.    
 
 
Chapter 8   Bibliography 
Department of Pharmacy Practice  41 JKKMMRF College of Pharmacy 
BIBLOGRAPHY 
1] Clincal pharmacy and therapeutics edited by Roger Walker and Cate Whittlesea, 
5th  Edition, Hematopoietic Disorders, Anemia, Pages : 769 – 778. 
2] WHO topics anemia. available http://www.who.int/topics/anemia/en/ 
3]  PubMed health Website – anemia and hemoglobin topics . available  
www.ncbi.nlm.nih.gov 
4] Applied therapeutics – The clinical use of drugs, Koda-Kimble and Young , 
pages 232-234. 
5] WHO (2011) . Global NutritionTargets 2025 : Anaemia policy brief . Available 
from:http://www.who.int/nutrition/publications/globaltargets2025_policybrief_a
naemia/en/  
6] National Family Health Survey, India, NFSH-3. Summary of findings. 2005-
2006. Available from http://rchiips.org/nfhs/volume_1.html 
7]  Anemia clinical Presentation, etiology, available. http:/emedicine.medscape. 
com/article/194575-clincal  
8] Pharmacotherapy handbook , 7th edition , Barbara G. wells , Terry L. 
schwingharmmer , Joseph T. Dipiro , Cecily V. Dipiro , pages : 363 – 369. 
9] EASTREN MAINE MEDICAL CENTRE WEBSITE. available from : 
http://www.emmc.org/anaemia-management/anemia-risk--factors.aspx: 
10] Johonson-Wimbley TD, Graham DY. Diagnosis and management of iron 
deficiency anaemia in the 21st century. Therap Adv gastroenterol .2011 ; 177-
184 . 
Chapter 8   Bibliography 
Department of Pharmacy Practice  42 JKKMMRF College of Pharmacy 
10] Ioannou GN, Spector J, Scott K, Rockey DC. Prospective evaluation of a 
clinical guideline for the diagnosis and management of iron deficiency anemia. 
Am J Med. 2002; 113(4):281-287. 
12] heamoglobin concentrations for the diagnosis of anaemia and assessment of 
severity , page no : 3, available.www.who.int/vmnis/indicators/haemoglobin.pdf 
13] Gowers WR An apparatus for the clinical estimation of haemoglobin  trans. 
clin.soc.Lond., 1879;12:64-67. 
14] Haldane J. The colorimetric  determination of hemoglobin . J physiol 1901 ;26: 
496-04. 
15] ICSH. recommendations for haemoglobinometry in human blood. Br J 
Haematol.1967; 13 (suppl:76-6) .  
16] ICSH recommendations for reference method for haemoglobinometry in human 
blood (ICSH standard 1995) and specifications for international 
haemiglobicyanide standard, 4th edition . J clin Path 1996 ;6:538-44 . 
17] van Kampen EJ , Zijlstra WJ . standardization of hemoglobinacynaide method . 
clin chim acta 1961 ;6:538-44 
18] Anemia in relation to body mass index and waist circumference among Chinese 
women , Y Quin , Alida melse-boonstra , Xiaoqun pan , baojun yuan , Yue Dai , 
Jinkou Zhao , Michael B zimmermann , Frans J kok , Minghao Zhou and 
Zimmin shi , Nutritional  journal , 2013 , 13:10 . 
19] Prevelance of anemia in kerala state , southern India – A Systematic Review , 
Journal of clinical and diagnostic research , 2017 Aug : vol. 11 , issue 8 , pages : 
Bc04-06 . 
20] Prevalence of iron Deficiency and Iron Deficiency  Anaemia in Adolescent Girls 
In A Teritary Care Hospital , Rekha Kumari ,Raushan Kumar Bharti , Kalpana 
Chapter 8   Bibliography 
Department of Pharmacy Practice  43 JKKMMRF College of Pharmacy 
Singh , Archana Sinha , Sudhir Kumar , Anand Saran And Uday Kumar , Journal 
of clinical and diagnostic research , 2017 Aug : vol. 11 , issue 8 , pages : Bc04-06 . 
21] Prevalence of iron deficiency anemia in chronic diarrhea and celiac disease – a 
western UP experience , Rana K Sherwani , Seema Alam , Kafil Akhtar , Bushra 
Abid , Khaliqur Rahman And Riaz Mehdi , Indian journal of hematology and 
blood Transfusion, March 2008, vol. 24, issue . 1, pages : 12-15. 
22] Prevalence of hematinics deficiency among female students and its correction , 
B C Mehta, R M Kabeer and Y. Patel Indian Journal of hematology and blood 
transfusion , 2007 december ; vol. 23 , issue . 3-4 , pages : 88-91 . 
23] Transfusion Therapy For Anaemia, Jayabose S , Tugal O, Ruddy R, Wuest D, 
And Ciavarella D , Journal of pediatric hematology / oncology, 1993 Aug, 
vol.15, issue.3, pages : 324-7. 
24] Dietary Intake , Prevalence, And The Effect Of Anemia On Various 
Morphophysiological Variables Of Postmenopausal Women Of North India , 
Kaur M , Journal Of Midlife Health , 2018 April-June Vol. 9 , Issue.2 , 72-78 .  
25] Iron Deficiency Anemia With Menorrhagia : Ferric Carboxymaltose A Safer 
Alternative To Blood Transfusion , Mishra V, Verneker R , Gandhi K , 
Choudhary S , Lamba S, Journal Of Midlife Health, 2018 April-June Vol.9 , 
Issue. 2 , Pages : 92-96. 
 
 
  
 
 
Chapter 9   Annexure 
Department of Pharmacy Practice  44 JKKMMRF College of Pharmacy 
DATA COLLECTION FORM 
Case no:    IP/OP NO : Height : 
      Age           sex  
  
 
Department : Weight: 
Discharged on : 
                                                        
                
Admitted on : 
 
Complaint at admission : 
Past history :  
Family  history : 
Drug allergies : 
Diagnosis : 
Date Dose & 
Frequency
Generic 
name 
Brand name 
      
     
      
      
     
      
      
      
      
      
      
      
     
      
Chapter 9   Annexure 
Department of Pharmacy Practice  45 JKKMMRF College of Pharmacy 
      
      
Hematology : 
RBcs : 
Haemoglobin level (gm/dl ) : 
Mcv :                       MCH:                 MCHC:   
Hct:  
Severity of Anemia :  
                                                         □ sever 
                                                         □ moderate 
                                                         □ mild 
blood transfusion therapy  :  
blood component : 
blood group : 
volume required : 
                      
